MaaT Pharma Announces Combined General Meeting on May 31, 20

Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a French clinical-stage biotech and a pioneer in the development of microbiome-based ecosystem therapies dedicated to improving survival

Related Keywords

France , French , Tony Garnier , Trophic Communications Corporate , Senior Pr Corporate Communications , Regulatory News , Annual General Meeting , French Commercial Code , Maat Pharma , Combined General Meeting , Microbiome Ecosystem Therapies , Euronext Paris , Communications Manager , Communications Corporate , Medical Communications , Jamaat , Dharma , Nnounces , Combined , Eneral , Meeting , 022 , Availability , Preparatory , Documents ,